McIntosh JK - Search Results

1

An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.

You L, He B, Xu Z, Uematsu K, Mazieres J, Fujii N, Mikami I, Reguart N, McIntosh JK, Kashani-Sabet M, McCormick F, Jablons DM. You L, et al. Among authors: mcintosh jk. Cancer Res. 2004 Aug 1;64(15):5385-9. doi: 10.1158/0008-5472.CAN-04-1227. Cancer Res. 2004. PMID: 15289346

2

Antitumor activity of recombinant interleukin 6 in mice.

Mulé JJ, McIntosh JK, Jablons DM, Rosenberg SA. Mulé JJ, et al. Among authors: mcintosh jk. J Exp Med. 1990 Mar 1;171(3):629-36. doi: 10.1084/jem.171.3.629. J Exp Med. 1990. PMID: 2307930 Free PMC article.

3

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.

McIntosh JK, Jablons DM, Mulé JJ, Nordan RP, Rudikoff S, Lotze MT, Rosenberg SA. McIntosh JK, et al. J Immunol. 1989 Jul 1;143(1):162-7. J Immunol. 1989. PMID: 2499626

4

Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.

Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Greenberg AS, et al. Cancer Res. 1992 Aug 1;52(15):4113-6. Cancer Res. 1992. PMID: 1638523

5

Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state.

Jablons DM, McIntosh JK, Mulé JJ, Nordan RP, Rudikoff S, Lotze MT. Jablons DM, et al. Among authors: mcintosh jk. Ann N Y Acad Sci. 1989;557:157-60; discussion 160-1. doi: 10.1111/j.1749-6632.1989.tb24008.x. Ann N Y Acad Sci. 1989. PMID: 2472087 No abstract available.

6

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

Jablons DM, Mulé JJ, McIntosh JK, Sehgal PB, May LT, Huang CM, Rosenberg SA, Lotze MT. Jablons DM, et al. Among authors: mcintosh jk. J Immunol. 1989 Mar 1;142(5):1542-7. J Immunol. 1989. PMID: 2783945

7

Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.

McIntosh JK, Mulé JJ, Travis WD, Rosenberg SA. McIntosh JK, et al. Cancer Res. 1990 Apr 15;50(8):2463-9. Cancer Res. 1990. PMID: 2317830

8

Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.

Hauser GJ, McIntosh JK, Travis WD, Rosenberg SA. Hauser GJ, et al. Among authors: mcintosh jk. Cancer Res. 1990 Jun 15;50(12):3503-8. Cancer Res. 1990. PMID: 2340500

9

Effect of recombinant human tumor necrosis factor alpha on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules.

Eisenthal A, McIntosh JK. Eisenthal A, et al. Among authors: mcintosh jk. Cancer Immunol Immunother. 1990;31(4):243-9. doi: 10.1007/BF01789176. Cancer Immunol Immunother. 1990. PMID: 2379220 Free PMC article.

10

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E. Rusch V, et al. Cancer Res. 1993 May 15;53(10 Suppl):2379-85. Cancer Res. 1993. PMID: 7683573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters